Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | SLC16A3 | O15427 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 7/20 | 0.54 |
| ▸ | MAPT | P10636 | 7/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.54 |
| ▸ | MAOB | P27338 | 4/20 | 0.54 |
| ▸ | ATM | Q13315 | 3/20 | 0.54 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8707677 | 0.82 | ALDH1A1 (0.55) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL30158125 | 0.82 | ALDH1A1 (0.55) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL8562232 | 0.81 | ALDH1A1 (0.52) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL17368890 | 0.77 | MAOB (0.71) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL16573482 | 0.74 | ALDH1A1 (0.52) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL29775307 | 0.74 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL12651892 | 0.74 | ALDH1A1 (0.72) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL22001542 | 0.74 | MEN1 (0.61) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL12651748 | 0.73 | MEN1 (0.74) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL21615668 | 0.73 | KMT2A (0.60) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9364569-B2 | Ultrasound contrast agents and process for the preparation thereof | BRACCO SUISSE S.A. (CH) | 2016-06-14 | — | — | US | claimed |
| EP-1289565-B1 | COMPOUNDS FOR TARGETING ENDOTHELIAL CELLS | BRACCO SUISSE SA (CH) | 2015-04-22 | — | — | EP | claimed |
| EP-1590006-B1 | ULTRASOUND CONTRAST AGENTS AND PROCESS FOR THE PREPARATION THEREOF | BRACCO SUISSE SA (CH) | 2010-09-08 | — | — | EP | claimed |
| US-20070196462-A1 | Composition and method for neuromuscular blockade | IMARX THERAPEUTICS, INC. (US) | 2007-08-23 | — | — | US | claimed |
| EP-0935415-B1 | IN VITRO METHODS FOR DELIVERING NUCLEIC ACIDS INTO A CELL | IMARX PHARMACEUTICAL CORP (US) | 2006-11-22 | — | — | EP | claimed |
| EP-1720522-A1 | ORAL CONTROLLED RELEASE SYSTEM FOR TARGETED DRUG DELIVERY INTO THE CELL AND ITS NUCLEUS FOR GENE THERAPY, DNA VACCINATION AND ADMINISTRATION OF GENE BASED DRUGS | Salvona LLC (US) | 2006-11-15 | — | — | EP | claimed |
| US-20060051297-A1 | Ultrasound contrast agents and process for the preparation thereof | BRACCO INTERNATIONAL B.V | 2006-03-09 | — | — | US | claimed |
| CN-1744921-A | Ultrasonic contrast agent and preparation method thereof | BRACCO INT BV (NL) | 2006-03-08 | — | — | CN | claimed |
| WO-2005084644-A1 | ORAL CONTROLLED RELEASE SYSTEM FOR TARGETED DRUG DELIVERY INTO THE CELL AND ITS NUCLEUS FOR GENE THERAPY, DNA VACCINATION AND ADMINISTRATION OF GENE BASED DRUGS | SALVONA LLC (US) | 2005-09-15 | — | — | WO | claimed |
| EP-1569619-A1 | PH TRIGGERED TARGETED CONTROLLED RELEASE SYSTEMS | Salvona LLC (US) | 2005-09-07 | — | — | EP | claimed |
| EP-0760684-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1997-03-12 | — | — | EP | claimed |
| US-5585112-A | TEMPERATURE-ACTIVATED FLUORINE-CONTAINING GAS; USEFUL IN ULTRASONIC IMAGING AND DRUG DELIVERY SYSTEMS; FDA ORANGE BOOK LISTED PATENT FOR PERFLUTREN | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-17 | — | — | US | claimed |
| EP-0740528-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1996-11-06 | — | — | EP | claimed |
| CN-1125389-A | Methods of preparing gas and gaseous precursor-filled microspheres | IMARX PHARMACEUTICAL CORP (US) | 1996-06-26 | — | — | CN | claimed |
| EP-0712293-A1 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER, Evan C (US) | 1996-05-22 | — | — | EP | claimed |
| WO-1995032006-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX, PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | claimed |
| WO-1995024184-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | UNGER EVAN C (US) | 1995-09-14 | — | — | WO | claimed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | claimed |
| WO-1994028780-A2 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER EVAN C (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1994028874-A1 | NOVEL THERAPEUTIC DELIVERY SYSTEMS | UNGER EVAN C (US) | 1994-12-22 | — | — | WO | claimed |